Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04754204 · ClinicalTrials.gov registry record

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients

A clinical trial, sponsored by Zoll Medical Corporation.

Completed
Registry status
585
Enrollment target

NCT04754204: Completed study, sponsored by Zoll Medical Corporation.

NCT04754204 is a clinical trial that has completed, run by Zoll Medical Corporation. The registered enrollment target is 585 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04754204 has completed, sponsored by Zoll Medical Corporation.

COMPLETED
Registry status
585 participants
Enrollment target

Study Summary

To determine the associations among biometric data, arrhythmias, subject-reported symptoms and subject wellness.

Primary Outcome

MCT Data Sets

Interventions

  • DEVICE Arrhythmia Management System (AMS)

Trial Details

FieldValue
Enrollment Target 585 participants
Start Date 2020-12-15
Est. Completion 2021-12-15
Zoll Medical Corporation

24 total trials

What the finished NCT04754204 record still lists

NCT04754204 is an observational study that tracks outcomes without assigning an intervention. The registered 585 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Arrhythmia Management System (AMS) is the first listed.

NCT04754204 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04754204 about?

NCT04754204 is a clinical study titled "Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients". To determine the associations among biometric data, arrhythmias, subject-reported symptoms and subject wellness.

What is the current status of trial NCT04754204?

This trial is currently completed. The enrollment target is 585 participants. The study started on 2020-12-15. Estimated completion is 2021-12-15.

What interventions are being tested in trial NCT04754204?

The interventions under investigation include: Arrhythmia Management System (AMS) (DEVICE).

Who is sponsoring clinical trial NCT04754204?

This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02803957 · 585 participants · NA

    Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair

  • NCT06680869 · 585 participants · Phase 3

    Early Amiodarone in Shockable Cardiac Arrest

  • NCT04134260 · 586 participants · Phase 3

    Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

  • NCT06100770 · 586 participants

    Aveir AR Coverage With Evidence Development (CED) Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04754204, the US trial registry maintained by the National Library of Medicine. NCT04754204 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.